BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 30, 2006
View Archived Issues
GlaxoSmithKline makes strides in third quarter
Read More
Preclinical experiments display potential of PRX-302 in prostatic disease
Read More
Liraglutide added to metformin improves glucose levels in type 2 diabetes
Read More
Studies detail darunavir pharmacokinetic interactions, efficacy
Read More
Long-term activity of tipranavir measured in RESIST trials
Read More
New PDE4/TNF-alpha inhibitors emerge from Nippon Shinyaku R&D
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
First study of CK-1827452 in humans reported
Read More
Hematide-related peptide active in experimental pure red cell aplasia
Read More
Studies show benefit of predialysis erythropoietin administration
Read More
Novel HIV integrase inhibitors patented by Merck & Co.
Read More
New deadlines for VaxGen's development of anthrax vaccine
Read More
Pliva receives approvals for generic Pravastatin Tablets
Read More
Dainippon Sumitomo revises domestic development plan for AC-5216
Read More
Neurogen acquires rights to aplindore
Read More
LX-211 cleared to begin pivotal studies in uveitis
Read More
Alnylam to study ALN-RSV01 for RSV
Read More
Applied NeuroSolutions and Lilly partner in Alzheimer's disease
Read More
IC-51 safe, effective in phase III Japanese encephalitis trial
Read More
Kiadis and Celmed to merge
Read More
MLN-3897 begins phase II study for rheumatoid arthritis
Read More
GlaxoSmithKline's antimalarial development continues
Read More
Solbec updates status of Coramsine program
Read More
New trials under way for ACV-1
Read More
QVA-149 to enter clinical development in 2007
Read More
Cellegy completes sale of assets to ProStrakan
Read More
PMI-001 demonstrates positive results in rheumatoid arthritis
Read More
Heplisav superior to Engerix-B in phase II study
Read More
Daiichi Sankyo files NDA for amlodipine besylate/olmesartan medoxomil
Read More
Banyu launches Pneumovax NP in Japan
Read More
Herceptin filed in Japan for operable breast cancer with HER2 overexpression
Read More
Pediatric exclusivity for Ambien and Ambien CR
Read More